Agenus, Inc. (AGEN)
4.08
-0.01
(-0.24%)
USD |
NASDAQ |
Dec 11, 16:00
4.08
0.00 (0.00%)
After-Hours: 20:00
Agenus Cash from Investing (Quarterly): 0.076M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 8.867M |
| Armata Pharmaceuticals, Inc. | -0.242M |
| Bionano Genomics, Inc. | -4.669M |
| Twist Bioscience Corp. | -12.40M |
| AIM ImmunoTech, Inc. | 0.296M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.74M |
| Cash from Financing (Quarterly) | 6.683M |
| Free Cash Flow | -89.31M |
| Free Cash Flow Per Share (Quarterly) | -0.4485 |
| Free Cash Flow to Equity (Quarterly) | 47.08M |
| Free Cash Flow to Firm (Quarterly) | -1.493M |
| Free Cash Flow Yield | -81.11% |